...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Differential Modulation by the GABA_B Receptor Allosteric Potentiator 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of Synaptic Transmission in the Rat Hippocampal CA1 Area
【24h】

Differential Modulation by the GABA_B Receptor Allosteric Potentiator 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of Synaptic Transmission in the Rat Hippocampal CA1 Area

机译:GABA_B受体变构增强剂2,6-二叔丁基-4-(3-羟基-2,2-二甲基丙基)-苯酚(CGP7930)在大鼠海马CA1区的突触传递的差分调制。

获取原文
获取原文并翻译 | 示例
           

摘要

The recently discovered GABA_B receptor-positive allosteric modulators enhanced the potency and efficacy of GABA_B receptor agonists in in vitro experiments.These GABA_B modulators also attenuated reward and anxiety in behavioral experiments without causing the untoward side effects associated with GABA_B receptor activation by agonist administration and hence exhibited potential therapeutic utility.However,the underlying molecular mechanisms enabling the GABA_B allosteric modulators to dissociate from the GABA_B agonistic side effects remain elusive.To address this question,we have examined the effects of a typical GABA_B modulator,2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930),on GABA_B receptor-mediated modulations of both the excitatory and the delayed inhibitory components of hippocampal CA1 synaptic transmission.Using baclofen as an agonist and a multielec-trode recording system,we recorded GABA_B receptor-mediated modulations of both the field excitatory postsynaptic potentials and the population spikes simultaneously,as well as the paired-pulse inhibition of the population spike.We found that CGP7930 selectively enhanced the baclofen-induced modulation of synaptic inhibition without having any significant effects on the synaptic excitation.Our experiments have therefore revealed a pathway-selective differential modulation of synaptic transmission by CGP7930.This finding provides a synaptic mechanism to support the hypothesis that GABA_B potentiators may be a better therapeutic alternative than GABA_B agonists for central nervous system disorders.
机译:最近发现的GABA_B受体阳性变构调节剂在体外实验中增强了GABA_B受体激动剂的效力和功效,这些GABA_B调节剂还减轻了行为实验中的奖赏和焦虑,而不会因激动剂给药而引起与GABA_B受体激活相关的不良副作用,因此发挥潜在的治疗作用。然而,使GABA_B变构调节剂能够从GABA_B激动剂副作用中解离的潜在分子机制仍然难以捉摸。为解决这个问题,我们研究了典型的GABA_B调节剂2,6-di-tert的作用。 -丁基-4-(3-羟基-2,2-二甲基丙基)-苯酚(CGP7930)对GABA_B受体介导的海马CA1突触传递的兴奋性和延迟抑制成分的调节。使用巴氯芬作为激动剂和多电极记录系统,我们记录了GABA_B受体介导的两种场刺激性调节突触电位和种群突增同时发生,以及种群突增的成对脉冲抑制。我们发现CGP7930有选择地增强了巴氯芬对突触抑制的调节,而对突触兴奋没有任何显着影响。因此,我们的实验揭示了CGP7930对突触传递的途径选择性差异调节。这一发现提供了一种突触机制,支持以下假设:对于中枢神经系统疾病,GABA_B增强剂比GABA_B激动剂可能是更好的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号